Penn Prevention CRS

Running trials

• Active, not recruiting

  A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV

  NCT06812494· Phase 2· Source

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  To Investigate Safety, Reactogenicity and Immunogenicity of VIR-1388 Compared With Placebo in Participants Without HIV

  NCT05854381· Phase 1· Source

• Completed

  A Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding a Native-like HIV Env Trimer and Interleukin-12 (INO-6160), Alone or in a Prime-boost Regimen With 3M-052-AF + Alum Adjuvanted VRC HIV Env Trimer 4571 in Adult Participants Without HIV

  NCT05828095· Phase 1· Source

• Completed

  INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit

  NCT04804072· Source

• Completed

  Pre-Exposure Prophylaxis for Transgender Women in the US and South America

  NCT04742491· Phase 2/3· Source

• Completed

  Evaluating the Safety and Immunogenicity of HIV-1 BG505 SOSIP.664 gp140 With TLR Agonist and/or Alum Adjuvants in Healthy, HIV-uninfected Adults

  NCT04177355· Phase 1· Source

• Completed

  Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men

  NCT02720094· Phase 2/3· Source